Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...
A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...
In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...
A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...
(Novo Nordisk’s semaglutide-based drugs stimulate the GLP-1 hormone.) The Biden administration last year proposed expanding coverage of weight-loss drugs for millions on Medicare and Medicaid ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...
Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular semaglutide medicines as one of the 15 additional drugs covered under ...